Global /United States /Healthcare /Medical Devices /CTKB
chevron_leftBack
Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc.

CTKB
NASDAQ: CTKB Delayed
4.44USD -2.8%
As of 13 June 2026, Cytek Biosciences, Inc. has a market cap of $570.76M USD, ranking #14254 globally and #2542 in the United States. It ranks #1271 in the Healthcare sector, and #254 in the Medical Devices industry.
Global Rank
14254
Country Rank
2542
Sector Rank
1271
Industry Rank
254
Key Stats
Market Cap
$570.76MUSD
Enterprise Value
$322.69MUSD
Revenue (TTM)
$201.49MUSD
EBITDA (TTM)
-$32.81MUSD
Net Income (TTM)
-$66.54MUSD
EBITDA Margin
-16%
Profit Margin
-33%
PS Ratio
2.8
PB Ratio
1.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Wenbin Jiang open_in_new
Employees
702
Founded
1990
IPO
23 Jul 2021
Website
cytekbio.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.8% -3.7% 3.2% -13% 6.2% 16%

News

Loading...

CTKB Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
CTKB
Cytek Biosciences Inc
ISIN: US23285D1090
Shares Out.:
129.143M1 Shares Float: 118.16M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
4.44 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Cytek Biosciences, Inc.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
30K%
25.8
$160.73B
28K%
56.7
$159.07B
28K%
25.6
DHR
$126.55B
22K%
34.7
SYK
$120.69B
21K%
38.3
$84.93B
15K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
18K%
22.2
$97.46B
84.32B EUR
17K%
36.7
7741
$61.41B
9.83T JPY
11K%
40.0
$45.47B
39.34B EUR
8K%
18.7
ALC
$36.38B
28.99B CHF
6K%
37.9
$30.06B
203.66B CNY
5K%
26.0
chevron_leftBack